Skip to main content
Premium Trial:

Request an Annual Quote

NIH Doles Out $21.5M to Help Labs Buy 'High-End' Proteomic, Genomic Tools

NEW YORK (GenomeWeb News) – The National Institutes of Health has set aside $21.5 million for 14 grants to help a number of academic labs buy high-end instruments, including mass spectrometers, sequencers, and supercomputers, the agency said today.
  • Stanford University received $543,750 for an ultra-high-throughput genome sequencing system that performs clonal amplification and pyrosequencing to support microbial genome sequencing; 
  • The University of California at Santa Barbara and the University of Virginia each received $2 million for an 800-megahertz nuclear magnetic resonance spectrometer. UCSB will study protein interactions with bacteria, and UVA will focus on biopolymers and membrane proteins; 
  • The University of California at Los Angeles received $1.2 million for a high-resolution, hybrid Fourier transform ion cyclotron resonance mass spectrometer to study neurodegenerative diseases, respiratory illnesses, and cancer;
  • The University of Maryland in Baltimore County received $1.5 million for a hybrid, 12 Tesla quadrupole/trap-Fourier transform ion cyclotron resonance mass spectrometer to characterize nucleic acids; and
  • The University of Washington received $500,000 for a multi-tiered proteomic compute cluster for protein chemistry studies to study lung injury diseases, toxicity, and drug-induced liver disease.
The one-time awards fund a maximum of $2 million to research institutions purchasing sophisticated instruments as part of biomedical research. The awards will be made through The National Center for Research Resources.
 
Information about the NIH's High-End Instrumentation program is here.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.